Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (14674)	9/16/2000 10:06:55 PM
From: Cacaito	Respond to of 17367

I am saying you are thinking wegglinginin dollars! I do not know for fact, but I suspect some drugs has being approve on that basis, cancer drugs come to mind, and tacrine comes to mind as being approved after public (pfe political clout)opinion pressure. Ligand got Targretin approve for all stages of CTCL, but only showed that it work in the stage III (the worst). Many cancer drugs are approved on the basis of shrinking tumors (onerecent from Pharmacia) in humans, not increase survival, but they go to Phase IV, which is a very strict and expenxsive (kills lots of profits for months to years)following of each patient on the drug post marketing. xoma TRY HARD to get subpart E approval (they do have dsignation) and did not get it. You did not get it. Call your indigenous prperson. ASK her xoma not me.